Cyclerion Therapeutics Inc (CYCN)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -3434.077 | -1790.879 | -126.892 | -51.549 | -59.123 | -113.882 | -33.466 |
Return on Equity (%) | 2192.646 | 1212.413 | -281.857 | -98.971 | -95.874 | -150.186 | -48.418 |
Return on Invested Capital (%) | 2172.36 | 1205.754 | -305.983 | -112.027 | -111.819 | -163.583 | -134.462 |
Operating Margin (%) | N/A | N/A | -2729.266 | -3388.589 | -1309.767 | -2712.492 | N/A |
Net Profit Margin (%) | N/A | N/A | -2729.266 | -3388.589 | -1310.173 | -2712.492 | N/A |
Book Value Per Share | N/A | N/A | 3.541 | 1.747 | 1.111 | 0.24 | 4.037 |
Earnings Per Share | N/A | N/A | -4.457 | -2.285 | -1.19 | -1.013 | -1.882 |
Cash Per Share | N/A | N/A | 3.438 | 1.598 | 1.243 | 0.307 | 2.708 |
Working Capital Per Share | N/A | N/A | 3.006 | 1.22 | 1.022 | 0.165 | 2.124 |
Operating Profit Per Share | N/A | N/A | 0.163 | 0.116 | 0.091 | 0.037 | N/A |
EBIT Per Share | N/A | N/A | -4.457 | -2.285 | -1.19 | -1.013 | -4.504 |
EBITDA Per Share | N/A | N/A | -4.457 | -2.285 | -1.19 | -1.013 | -4.504 |
Free Cash Flow Per Share | N/A | N/A | -4.305 | -2.308 | -1.2 | -1.014 | -1.882 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | N/A | 27,6M | 34,05M | 43,41M | 43,52M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 43,49M | 43,52M | 43,53M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 8,92M |
Ratio cours/bénéfice | -1,71 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,19 |
Ratio prix/valeur comptable | 0,8 |
Rendement de dividende | - |
Actions en circulation | 2,71M |
Volume moyen (1 semaine) | 61,14k |
Volume moyen (1 mois) | 288,64k |
Variation sur 52 semaines | -11,78% |
Plus haut sur 52 semaines | 9,4699 |
Plus bas sur 52 semaines | 1,27 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales